Sodium Phenylbutyrate
Overview
Sodium Phenylbutyrate is a drug used in the treatment of urea cycle disorders, where it acts as an ammonia scavenger to help facilitate the excretion of nitrogen. It is often administered to patients with certain enzyme deficiencies to prevent the accumulation of toxic levels of ammonia in the body.
API suppliers (5)
Suppliers of Sodium Phenylbutyrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 5 suppliers.
1 of 5 holds a GMP certificate on record in the EU or UK registers
- SRI KRISHNA PHARMACEUTICALS LTDIndia1 active DMF GMP on record
- PH HEALTH LTD1 active DMF
- STHREE CHEMICALS LLCIndia1 active DMF
- NAVINTA LLCUnited States1 active DMF
- NEW HORIZON PHARMA US INCUnited States1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (13 approved US products), the latest listed US patent on Sodium Phenylbutyrate expires 17 Oct 2036. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- decanoate
- Canonical SMILES
- CCCCCCCCCC(=O)[O-]
- InChIKey
- GHVNFZFCNZKVNT-UHFFFAOYSA-M
Therapeutic areas
Do you supply Sodium Phenylbutyrate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.